These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9636600)

  • 1. Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation.
    Nakamura M; Fuchinoue S; Sato S; Hoshino T; Sawada T; Sageshima J; Kitajima K; Tojinbara T; Fujita S; Nakajima I; Agishi T; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1477-8. PubMed ID: 9636600
    [No Abstract]   [Full Text] [Related]  

  • 2. Two cases of tacrolimus-induced alopecia following kidney transplantation.
    Ushigome H; Yoshimura N; Okamoto M; Najima H; Hamajima T; Nakai I; Oka T
    Transplant Proc; 1999 Nov; 31(7):2885-6. PubMed ID: 10578326
    [No Abstract]   [Full Text] [Related]  

  • 3. Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.
    Lagget M; Marzano A; Actis GC; Leone N; Ciancio A; Salizzoni M; Rizzetto M
    Transplant Proc; 1998 Aug; 30(5):1863-4. PubMed ID: 9723312
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible posterior leukoencephalopathy syndrome associated with tacrolimus therapy.
    Nakazato T; Nagasaki A; Nakamura K; Okudaira T; Oshiro A; Miyagi T; Shinjo T; Taira N; Masuda M; Takasu N
    Intern Med; 2003 Jul; 42(7):624-5. PubMed ID: 12879959
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute headache as a presenting symptom of tacrolimus encephalopathy.
    Kiemeneij IM; de Leeuw FE; Ramos LM; van Gijn J
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1126-7. PubMed ID: 12876250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506).
    Small SL; Fukui MB; Bramblett GT; Eidelman BH
    Ann Neurol; 1996 Oct; 40(4):575-80. PubMed ID: 8871576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful retransplantation using rapamycin in a patient with previous calcineurin inhibitor-induced posterior leukoencephalopathy syndrome.
    Afzali B; Goldsmith DJ
    Clin Nephrol; 2003 Mar; 59(3):225-8. PubMed ID: 12653269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.
    Langrehr JM; Klupp J; Junge G; Jonas S; Neuhaus R; Bechstein WO; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2330-1. PubMed ID: 11377549
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: A single-center experience at the University of Tokyo.
    Tamura S; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Murai N; Makuuchi M
    Transplant Proc; 2004 Dec; 36(10):3242-4. PubMed ID: 15686738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
    Friemann S; Feuring E; Padberg W; Ernst W
    Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504
    [No Abstract]   [Full Text] [Related]  

  • 13. Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation.
    Frühauf NR; Koeppen Dagger S; Saner FH; Egelhof Dagger T; Stavrou G; Nadalin S; Broelsch CE
    Liver Transpl; 2003 Sep; 9(9):983-5. PubMed ID: 12942462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of immunosuppressive agents after living related donor liver transplantation.
    Tanaka M; Otobe Y; Hashimoto T; Shimizu Y; Suzuki T; Nakamura Y; Itoh K; Satoh M; Ueda N; Manabe T
    Transplant Proc; 1996 Aug; 28(4):2402-3. PubMed ID: 8769268
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept.
    Ringe B; Braun F; Lorf T; Canelo R; Schütz E; Sattler B; Ramadori G
    Transplant Proc; 1998 Jun; 30(4):1415-6. PubMed ID: 9636573
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG; Lodge JP
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
    Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoral-based immunosuppression in living-related donor liver transplantation.
    Liu PP; Chen CL; Chen YS; Wang CC; Chiang YC; Goto S; Cheng YF; Huang TL; Eng HL; Cheung HK; Jawan B
    Transplant Proc; 1998 Nov; 30(7):3550-1. PubMed ID: 9838554
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
    Alberti D; Reding R; Otte JB; Falchetti D; Rigamonti W; Caccia G; Sokal E; de Ville de Goyet J
    Transplant Proc; 1998 Aug; 30(5):1858-60. PubMed ID: 9723310
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reversible cyclosporin A-induced leukoencephalopathy: a case report and differential diagnosis discussion].
    Lingesleben A; Hoffmann KT; Oppert M; Irlbacher K; Röricht S; Meyer BU
    Rontgenpraxis; 2000; 53(1):25-8. PubMed ID: 10943139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.